Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients - Contacts and Locations

Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients

This study is currently recruiting participants.

Study NCT00255918. Last updated on September 19, 2008. Information provided by National Institute of Mental Health (NIMH)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00255918

Contacts


Contact: Robert Freedman, MD	303-315-8403	Robert.Freedman@UCHSC.edu

Locations


United States, Colorado
	University of Colorado General Clinical Research Center	Recruiting
	Denver, Colorado, United States, 80262
	Contact: Robert Freedman, MD 303-315-8403 Robert.Freedman@UCHSC.edu
	Principal Investigator: Robert Freedman, MD
	Sub-Investigator: Ann Olincy, MD

Sponsors and Collaborators

National Institute of Mental Health (NIMH)

Investigators


Principal Investigator:	Robert Freedman, MD	University of Colorado at Denver and Health Sciences Center